Breaking News

UnitedHealth grapples with fresh security threats, customer backlash

February 25, 2025

STAT+ | Under siege after a tragedy, UnitedHealth grapples with fresh security threats and a customer backlash

Thrust into the center of public anger, the conglomerate has become the poster child of a dysfunctional health care system

By Tara Bannow, Bob Herman, Casey Ross, and Lizzy Lawrence


Covid, inflation, and Supreme Court blamed for steep drop in Native American medical school enrollment

Native American leaders say efforts to boost enrollment should not be affected by affirmative action ruling and Trump DEI executive orders

By Usha Lee McFarling


STAT+ | Eli Lilly to lower price of Zepbound vials, offer more doses

The pharma giant is seeking to draw patients away from cheap, compounded copies of weight loss medications.

By Elaine Chen



Adobe

STAT+ | Some NIH study sections will resume grant reviews, but final funding decisions are still in limbo

While some of the agency's study sections will resume, advisory council meetings, which make final funding decisions, seem to still be held up.

By Megan Molteni and Usha Lee McFarling


Opinion: 'Ultra-processed food' is too broad a term to be useful

Legislatures, governors, government agencies, and plaintiff attorneys are taking action against ultra-processed foods, but there is no clear definition.

By Chris Gismondi and Megan Kinney


Opinion: What academic research could learn from college athletics

Federal rules have fenced off academic researchers from business-funded basic science — just as NCAA rules constrained athletes.

By Morris W. Foster


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Daily Recap? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2025, All Rights Reserved.

No comments